| Bethanie Jones, PA-C | |
|
200 St Lukes Ln Ste 100, Stroudsburg, PA 18360-6218 | |
| (484) 503-4673 | |
| (833) 222-9420 |
| Full Name | Bethanie Jones |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 4 Years |
| Location | 200 St Lukes Ln Ste 100, Stroudsburg, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598372286 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | MA061884 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lehigh Valley Hospital - Pocono | East stroudsburg, PA | Hospital |
| St Luke's Hospital - Monroe Campus | Stroudsburg, PA | Hospital |
| St Luke's Hospital - Anderson Campus | Easton, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Family Care Centers Inc | 5395649347 | 197 |
| St Luke's Physician Group Inc | 6709798333 | 1739 |
News Archive
Necrotizing enterocolitis is an intestinal disease that afflicts about one in 10 extremely premature infants and is fatal in nearly one-third of cases. The premature infant gut is believed to react to colonizing bacteria, causing damage to the intestinal walls and severe infection.
Meda has signed an agreement to acquire the US development company Acton Pharmaceuticals, Inc. ("Acton") including the proprietary product Aerospan. Aerospan is an inhaler for the treatment of asthma that contains the active substance Flunisolide.
One in three patients hospitalized for medical problems experienced a drop in their red blood cell count due to the hospitalization – a concept called hospital-acquired anemia, new research showed.
AEterna Zentaris Inc. has presented a poster outlining Phase 1 results for its orally-active tubulin and topoisomerase II inhibitor compound, AEZS-112, in patients with advanced solid tumors or lymphoma, which may potentially provide a new therapeutic approach for the treatment of cancer.
Merck, known as MSD outside the United States and Canada, today announced results from a Phase II trial for odanacatib, an investigational cathepsin K (cat-K) inhibitor in development for the treatment of osteoporosis in post-menopausal women.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bethanie Jones, PA-C 126 Burma Rd, Mountain Top, PA 18707-2021 Ph: (570) 902-5258 | Bethanie Jones, PA-C 200 St Lukes Ln Ste 100, Stroudsburg, PA 18360-6218 Ph: (484) 503-4673 |
News Archive
Necrotizing enterocolitis is an intestinal disease that afflicts about one in 10 extremely premature infants and is fatal in nearly one-third of cases. The premature infant gut is believed to react to colonizing bacteria, causing damage to the intestinal walls and severe infection.
Meda has signed an agreement to acquire the US development company Acton Pharmaceuticals, Inc. ("Acton") including the proprietary product Aerospan. Aerospan is an inhaler for the treatment of asthma that contains the active substance Flunisolide.
One in three patients hospitalized for medical problems experienced a drop in their red blood cell count due to the hospitalization – a concept called hospital-acquired anemia, new research showed.
AEterna Zentaris Inc. has presented a poster outlining Phase 1 results for its orally-active tubulin and topoisomerase II inhibitor compound, AEZS-112, in patients with advanced solid tumors or lymphoma, which may potentially provide a new therapeutic approach for the treatment of cancer.
Merck, known as MSD outside the United States and Canada, today announced results from a Phase II trial for odanacatib, an investigational cathepsin K (cat-K) inhibitor in development for the treatment of osteoporosis in post-menopausal women.
› Verified 7 days ago
Sethuraman Muthiah, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 6977 Rte 611 Olympia Plaza, Stroudsburg, PA 18360 Phone: 570-424-2025 Fax: 570-424-2028 | |
Mr. Justin John Kuna, PA-C Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 100 St Lukes Ln, Stroudsburg, PA 18360 Phone: 866-785-8537 | |
Melissa Zegar, D.O. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 600 Commerce Blvd, Stroudsburg, PA 18360 Phone: 570-426-2700 Fax: 570-424-1252 | |
Mr. Biren Mangani, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 100 St Lukes Ln, Stroudsburg, PA 18360 Phone: 484-526-6643 | |
Dr. Sulagna De, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: Route 611 Stroud Bldg Suite 100b, Stroudsburg, PA 18360 Phone: 570-420-5435 Fax: 570-420-5437 | |
Leah Stahler, PA-C Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 100 St Lukes Ln, Stroudsburg, PA 18360 Phone: 886-785-8537 |